Cellular bioenergetics after erythropoietin therapy in chronic renal failure.

After erythropoietin (rHuEPO) therapy, patients with chronic renal failure (CRF) do not improve peak O2 uptake (VO2 peak) as much as expected from the rise in hemoglobin concentration ([Hb]). In a companion study, we explain this phenomenon by the concurrent effects of fall in muscle blood flow afte...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Marrades, R M, Alonso, J, Roca, J, González de Suso, J M, Campistol, J M, Barberá, J A, Diaz, O, Torregrosa, J V, Masclans, J R, Rodríguez-Roisin, R, Wagner, P D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507285/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8621800/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118647
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!